Treatment satisfaction with siponimod in patients with advancing relapsing multiple sclerosis: Interim results of the EXCHANGE study

被引：0
|
作者：
Cohan, S. L. [1 ,2 ]
Fox, R. J. [3 ]
Mao-Draayer, Y. [4 ]
Bar-Or, A. [5 ,6 ]
Cox, G. Mavrikis [7 ]
Meng, X. [7 ]
Cruz, L-A [7 ]
Weinstock-Guttman, B. [8 ]
机构：
[1] Providence Hlth & Serv, Providence Brain & Spine Inst, Portland, OR USA
[2] Providence Hlth & Serv, Providence Multiple Sclerosis Ctr, Portland, OR USA
[3] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Univ Michigan, Multiple Sclerosis Ctr, Autoimmun Ctr Excellence, Ann Arbor, MI 48109 USA
[5] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1145
引用
收藏
页码：901 / 902
页数：2
相关论文
共 50 条
  • [31] Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study)
    Fernandez, Oscar
    Duran, Eduardo
    Ayuso, Teresa
    Hernandez, Luis
    Bonaventura, Inmaculada
    Forner, Mireia
    PLOS ONE, 2017, 12 (10):
  • [32] Factors affecting disease outcomes and adherence in patients with relapsing multiple sclerosis using RebiSmart: interim results of the international, observational SMART study
    Bayas, A.
    Ouallet, J-C.
    Kallmann, B.
    Fulda, U.
    Marhardt, K.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 484 - 485
  • [33] Interim Analysis Results of an Observational, Retrospective, Multicenter Study to Assess the Effectiveness of Fingolimod Treatment in Clinical Practice in Patients with Relapsing-Remitting Multiple Sclerosis in Spain: The NEXT Study
    Jose Mallada, Javier
    Barrero, Francisco
    Martinez, Marisa
    Marzo, Eugenia
    Meca Lallana, Virginia
    Javier Ricart, Francisco
    Garcia, Eli
    NEUROLOGY, 2016, 86
  • [34] Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
    Selmaj, Krzysztof
    Li, David K. B.
    Hartung, Hans-Peter
    Hemmer, Bernhard
    Kappos, Ludwig
    Freedman, Mark S.
    Stueve, Olaf
    Rieckmann, Peter
    Montalban, Xavier
    Ziemssen, Tjalf
    Auberson, Lixin Zhang
    Pohlmann, Harald
    Mercier, Francois
    Dahlke, Frank
    Wallstroem, Erik
    LANCET NEUROLOGY, 2013, 12 (08): : 756 - 767
  • [35] Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the TYSABRI® Observational Programme in Canada
    Jacques, F.
    Bhan, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 695 - 696
  • [36] Scoring treatment response in patients with relapsing multiple sclerosis
    Sormani, M. P.
    Rio, J.
    Tintore, M.
    Signori, A.
    Li, D.
    Cornelisse, P.
    Stubinski, B.
    Stromillo, M. L.
    Montalban, X.
    De Stefano, N.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 605 - 612
  • [37] EFFICACY AND SAFETY OF NATALIZUMAB TREATMENT FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: INTERIM RESULTS OF THE TYSABRI® OBSERVATIONAL PROGRAMME IN THE UK
    Hanna, Jerome
    Rosen, Jan Paul
    Smethurst, Caroline
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [38] Repurposing the multiple sclerosis drug Siponimod for osteoporosis treatment
    Hu, Sitao
    Hu, Yangyang
    Tan, Zenglin
    Zhou, Chengyu
    Zhang, Cheng
    Yin, Sheng
    Chen, Xiaojun
    Chen, Kai
    Wang, Lu
    Chen, Lei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 974
  • [39] Patient reported adherence and treatment satisfaction in irish relapsing remitting multiple sclerosis patients treated with fingolimod
    Murphy, N.
    Tyaransen, K.
    Horgan, E.
    MacIver, R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 953 - 953
  • [40] The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
    Valis, Martin
    Achiron, Anat
    Hartung, Hans Peter
    Mares, Jan
    Ticha, Veronika
    Stourac, Pavel
    Haluskova, Simona
    Angelucci, Francesco
    Pavelek, Zbysek
    DRUGS IN R&D, 2023, 23 (04) : 331 - 338
12345